• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DBV Technologies SA

+ Add to Watchlist


41.0000 EUR 0.8900 2.22%

As of 11:37:19 ET on 11/28/2014.

Snapshot for DBV Technologies SA (DBV)

Open: 40.0100 Day's Range: 39.7600 - 41.1400 Volume: 30,983
Previous Close: 40.1100 52wk Range: 9.3000 - 41.4300 1-Yr Rtn: +321.81%

Stock Chart for DBV

No chart data available.
  • DBV:FP 41.0000
  • 1D
  • 1M
  • 1Y
Interactive DBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -1.4200
Est. EPS (EUR) (12/2014) -1.2990
Est. PEG Ratio -
Market Cap (M EUR) 773.63
Shares Outstanding (M) 18.87
30 Day Average Volume 75,169
Price/Book (mrq) 15.3144
Price/Sale (ttm) 3,068.1637
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/16/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for DBV

DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.

Pierre-Henri BenhamouChairman/CEO/Co-FounderDavid SchilanskyChief Financial Officer
Charles RubanChief Development OfficerBertrand DupontChief Industrial Ofcr/Co-Founder
More Company Profile & Key Executives for DBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil